Processa Pharmaceuticals Acquires Vidya Therapeutics and Announces $200 Million Private Placement

Leila Ahmed North America Legal Chronicle
Tagged:

Katten Muchin Rosenman has advised Processa Pharmaceuticals, Inc. Cooley has advised Vidya Therapeutics, Inc. Mintz has advised the placement agents. Processa Pharmaceuticals, Inc. (NASDAQ: PRCT) has…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here